As of May 23, 2025, Aeterna Zentaris Inc (AEZS.TO) reports a EV/EBITDA of 0.72.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Aeterna Zentaris Inc's EV/EBITDA to Peers
To better understand Aeterna Zentaris Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Aeterna Zentaris Inc (AEZS.TO) | 0.72 |
| X4 Pharmaceuticals Inc (XFOR) | 2.64 |
| Leap Therapeutics Inc (LPTX) | 0.62 |
| Aptinyx Inc (APTX) | 0.15 |
| Old Ayala Inc (AYLA) | 0.10 |
| Synlogic Inc (SYBX) | 0.10 |
Compared to its competitors, Aeterna Zentaris Inc's EV/EBITDA is among the highest compared to peers, suggesting the market values the company at a premium, possibly due to growth expectations.